EDITORIAL
Open Access
- 4 September 2006
- journal article
- Published by Wiley in Transfusion
- Vol. 46 (9) , 1652-1656
- https://doi.org/10.1111/j.1537-2995.2006.00924_1.x
Abstract
No abstract availableThis publication has 47 references indexed in Scilit:
- Antenatal administration of Rh‐immune globulin causes significant increases in the immunomodulatory cytokines transforming growth factor‐β and prostaglandin E2Transfusion, 2006
- Innate Immunity: New Approaches to Understanding Its Clinical SignificanceAmerican Journal of Clinical Pathology, 2005
- Intravenous (IV) anti‐D and IV immunoglobulin achieve acute platelet increases by different mechanisms: modulation of cytokine and platelet responses to IV anti‐D by FcγRIIa and FcγRIIIa polymorphismsBritish Journal of Haematology, 2004
- Anti-D initially stimulates an Fc-dependent leukocyte oxidative burst and subsequently suppresses erythrophagocytosis via interleukin-1 receptor antagonistBlood, 2003
- Anti‐D (WinRho SD™) treatment of children with chronic autoimmune thrombocytopenic purpura stimulates transient cytokine/chemokine productionAmerican Journal of Hematology, 2002
- Clinical significance of IgG Fc receptors and FcγR-directed immunotherapiesImmunology Today, 1997
- T Cell-Dependent B Cell ActivationAnnual Review of Immunology, 1993
- Experimental Studies on the Prevention of Rh Haemolytic DiseaseBMJ, 1961
- The Influence of Mother-Child ABO Incompatibility on Rh ImmunisationVox Sanguinis, 1956
- ANÆMIA FROM BLEEDING OF THE FETUS INTO THE MOTHER'S CIRCULATIONThe Lancet, 1954